Page 83

Mayo_2017

SOLUCIÓN DE PROBLEMAS CLÍNICOS 629 5. Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sánchez-Guerrero J, Maciuca R, et al; LUNAR Investigator Group. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.Arthritis Rheum 2012; 64 (4): 1215-26. doi: 10.1002/art.34359. Epub 2012 Jan 9G 6. Appel G, Contreras G, Dooley MA, Ginzler EMD, Isenberg D, Jayne D, et al and the Aspreva Lupus Management Study Group. Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis”. JASN 2009; 20 (5): 110312. Mujer joven con síndrome nefrótico - F. González et al Rev Med Chile 2017; 145: 623-629


Mayo_2017
To see the actual publication please follow the link above